Subic Z, Drobne D, Novak G. High persistence and efficacy of ustekinumab as a first-line biological therapy in inflammatory bowel disease: a real-world cohort study. Scand J Gastroenterol 2025 Dec 8:1-9. doi: 10.1080/00365521.2025.2597263.
PMID: 41360710